Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7252)
All Articles published online
|
Publishing Process of This Article
|
Aug 21, 2017 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Tan YW, Zhou XB, Ye Y, He C, Ge GH. Diagnostic value of FIB-4, aspartate aminotransferase-to-platelet ratio index and liver stiffness measurement in hepatitis B virus-infected patients with persistently normal alanine aminotransferase. World J Gastroenterol 2017; 23(31): 5746-5754 [PMID: 28883700 DOI: 10.3748/wjg.v23.i31.5746] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v23/i31/5746.htm |
| Number | Citing Articles |
| 1 |
Wentao Wang, Xueqi Zhao, Guiping Li, Lin Wang, Yizhi Chen, Ke Ma, Guang Chen, Tao Chen, Meifang Han, Qin Ning, Xiping Zhao. Diagnostic thresholds and performance of noninvasive fibrosis scores are limited by age in patients with chronic hepatitis B. Journal of Medical Virology 2019; 91(7): 1279 doi: 10.1002/jmv.25435
|
| 2 |
Chi Zhang, Jia-Wen Li, Zhao Wu, Hong Zhao, Gui-Qiang Wang. Significant Histologic Changes Are Not Rare in Treatment-naive Hepatitis B Patients with Normal Alanine Aminotransferase Level: A Meta-analysis. Journal of Clinical and Translational Hepatology 2021; 0(000): 000 doi: 10.14218/JCTH.2020.00136
|
| 3 |
Da-Wu Zeng, Zu-Xiong Huang, Meng-Xin Lin, Na-Ling Kang, Xin Lin, Ya-Nan Li, Yue-Yong Zhu, Yu-Rui Liu. A novel HBsAg-based model for predicting significant liver fibrosis among Chinese patients with immune-tolerant phase chronic hepatitis B: a multicenter retrospective study. Therapeutic Advances in Gastroenterology 2021; 14: 175628482110106 doi: 10.1177/17562848211010675
|
| 4 |
Na-Ling Kang, Jie-Min Zhang, Meng-Xin Lin, Xu-Dong Chen, Zu-Xiong Huang, Yue-Yong Zhu, Yu-Rui Liu, Da-Wu Zeng. Serum ceruloplasmin can predict liver fibrosis in hepatitis B virus-infected patients. World Journal of Gastroenterology 2020; 26(27): 3952-3962 doi: 10.3748/wjg.v26.i27.3952
|
| 5 |
Edward John Gane, Michael R. Charlton, Rosmawati Mohamed, Jose Decena Sollano, Kyaw Soe Tun, Thuy Thi Thu Pham, Diana Alcantara Payawal, Rino Alvani Gani, David Handojo Muljono, Subrat Kumar Acharya, Hui Zhuang, Akash Shukla, Kaushal Madan, Neeraj Saraf, Satyendra Tyagi, Karam Romeo Singh, Ian Homer Yee Cua, Ganbolor Jargalsaikhan, Davadoorj Duger, Wattana Sukeepaisarnjaroen, Hery Djagat Purnomo, Irsan Hasan, Laurentius Adrianto Lesmana, Cosmas Rinaldi Adithya Lesmana, Khin Pyone Kyi, Win Naing, Allampura Chandrashekar Ravishankar, Sanjay Hadigal. Asian consensus recommendations on optimizing the diagnosis and initiation of treatment of hepatitis B virus infection in resource‐limited settings. Journal of Viral Hepatitis 2020; 27(5): 466 doi: 10.1111/jvh.13244
|
| 6 |
Minmin Zhu, Hui Wang, Tao Lou, Pian Xiong, Jiebing Zhang, Lele Li, Yuchao Sun, Yingping Wu. Current treatment of chronic hepatitis B: Clinical aspects and future directions. Frontiers in Microbiology 2022; 13 doi: 10.3389/fmicb.2022.975584
|
| 7 |
Ping Fan, Lan-Qing Li, En-Qiang Chen. The urgency to expand the antiviral indications of general chronic hepatitis B patients. Frontiers in Medicine 2023; 10 doi: 10.3389/fmed.2023.1165891
|
| 8 |
Yafei Guo, Lingan Wang. Comment on “48-Week Outcome after Cessation of Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Patient and the Associated Factors with Relapse”. Canadian Journal of Gastroenterology and Hepatology 2019; 2019: 1 doi: 10.1155/2019/4927083
|
| 9 |
Shun Li, Lichen Shi, Xiaoqian Xu, Hao Wang, Hong You, Jidong Jia, Yuanyuan Kong. Systematic review with meta‐analysis: Significant histological changes among treatment‐naïve chronic hepatitis B patients with normal alanine aminotransferase levels by different criteria. Alimentary Pharmacology & Therapeutics 2023; 58(7): 648 doi: 10.1111/apt.17658
|
| 10 |
Qian Luo, Yongmei Li, Lan Luo, Wanglun Diao. Comparisons of the accuracy of radiation diagnostic modalities in brain tumor. Medicine 2018; 97(31): e11256 doi: 10.1097/MD.0000000000011256
|
| 11 |
Lin Wang, Yiqi Liu, Qixin Gu, Chi Zhang, Lei Xu, Lei Wang, Cuiying Chen, Xueen Liu, Hong Zhao, Hui Zhuang. Serum N-Glycan Markers for Diagnosing Significant Liver Fibrosis and Cirrhosis in Chronic Hepatitis B Patients with Normal Alanine Aminotransferase Levels. Engineering 2023; 26: 151 doi: 10.1016/j.eng.2023.03.008
|
| 12 |
Li Chen, Junjie Shi, Zhonghua Lu, Yun Ye, Xinbei Zhou, Youwen Tan. Baseline HBsAg levels associated with HBsAg loss in HBeAg-negative chronic hepatitis B infection with persistently normal alanine aminotransferase. Clinics and Research in Hepatology and Gastroenterology 2019; 43(3): 310 doi: 10.1016/j.clinre.2018.10.017
|
| 13 |
Guilherme Moura Cunha, Patrick J Navin, Kathryn J Fowler, Sudhakar K Venkatesh, Richard L Ehman, Claude B Sirlin. Quantitative magnetic resonance imaging for chronic liver disease. The British Journal of Radiology 2021; 94(1121): 20201377 doi: 10.1259/bjr.20201377
|
| 14 |
Sabina Więcek, Halina Woś, Andrzej Pogorzelski, Bożena Kordys-Darmolinska, Henryk Mazurek, Urszula Grzybowska-Chlebowczyk. Assessment of Selected Parameters of Liver Fibrosis and Inflammation in Patients with Diagnosed Cystic Fibrosis. Mediators of Inflammation 2020; 2020: 1 doi: 10.1155/2020/5696185
|
| 15 |
Zhiqiang Xu, Jinfang Zhao, Jiaye Liu, Yi Dong, Fuchuan Wang, Jianguo Yan, Lili Cao, Pu Wang, Aiqin Li, Jing Li, Shishu Zhu, Yanwei Zhong, Min Zhang, Fu-Sheng Wang. Assessment of liver fibrosis by transient elastography in young children with chronic hepatitis B virus infection. Hepatology International 2021; 15(3): 602 doi: 10.1007/s12072-021-10194-7
|
| 16 |
Yuting Diao, Juan Tang, Xuerong Wang, Wei Deng, Jing Tang, Chunfang You. Metabolic Syndrome, Nonalcoholic Fatty Liver Disease, and Chronic Hepatitis B: A Narrative Review. Infectious Diseases and Therapy 2023; 12(1): 53 doi: 10.1007/s40121-022-00725-6
|
| 17 |
Yanping Chen, Yanping Li, Na Li, Xiude Fan, Chunyan Li, Pingping Zhang, Qunying Han, Zhengwen Liu. A Noninvasive Score to Predict Liver Fibrosis in HBeAg-Positive Hepatitis B Patients with Normal or Minimally Elevated Alanine Aminotransferase Levels. Disease Markers 2018; 2018: 1 doi: 10.1155/2018/3924732
|
| 18 |
Xin Shu, Haixia Sun, Xiaoan Yang, Yifan Jia, Peiyan Xu, Hong Cao, Ka Zhang. Correlation of effective hepatic blood flow with liver pathology in patients with hepatitis B virus. Liver Research 2021; 5(4): 243 doi: 10.1016/j.livres.2021.11.003
|
| 19 |
Na-Ling Kang, Jie-Min Zhang, Meng-Xin Lin, Xu-Dong Chen, Zu-Xiong Huang, Yue-Yong Zhu, Yu-Rui Liu, Da-Wu Zeng. Serum ceruloplasmin can predict liver fibrosis in hepatitis B virus-infected patients. World Journal of Gastroenterology 2020; 26(27): 3948 doi: 10.3748/wjg.v26.i27.3948
|
| 20 |
宇行 刘. Research Progress in Histological Features and Related Influencing Factors of Chronic Hepatitis B Patients with Persistent Normal ALT. Advances in Clinical Medicine 2023; 13(05): 8702 doi: 10.12677/ACM.2023.1351216
|
| 21 |
Hong Zhou, Jun Long, Han Hu, Cai-Yun Tian, Shi-De Lin. Liver stiffness and serum markers for excluding high-risk varices in patients who do not meet Baveno VI criteria. World Journal of Gastroenterology 2019; 25(35): 5323-5333 doi: 10.3748/wjg.v25.i35.5323
|
| 22 |
Sufang Wei, Qiuli Xie, Guichan Liao, Hongjie Chen, Meixin Hu, Xiaoli Lin, Hong Li, Jie Peng. Patients with chronic hepatitis B who have persistently normal alanine aminotransferase or aged < 30 years may exhibit significant histologic damage. BMC Gastroenterology 2024; 24(1) doi: 10.1186/s12876-024-03208-9
|
| 23 |
Yuting Diao, Danqing Hu, Xue Hu, Peng Wang, Xiaojing Wang, Xiaoping Luo, Hongwu Wang, Qin Ning. The Role of Metabolic Factors and Steatosis in Treatment-Naïve Patients with Chronic Hepatitis B and Normal Alanine Aminotransferase. Infectious Diseases and Therapy 2022; 11(3): 1133 doi: 10.1007/s40121-022-00629-5
|
| 24 |
H. Ben Ayed, M. Koubaa, S. Yaich, K. Rekik, T. Ben Jemaa, I. Maaloul, C. Marrekchi, J. Damak, M. Ben Jemaa. A new combined predicting model using a non-invasive score for the assessment of liver fibrosis in patients presenting with chronic hepatitis B virus infection. Médecine et Maladies Infectieuses 2019; 49(8): 607 doi: 10.1016/j.medmal.2019.02.004
|
| 25 |
Milan J Sonneveld, Willem P Brouwer, Henry L-Y Chan, Teerha Piratvisuth, Ji-Dong Jia, Stefan Zeuzem, Yun-Fan Liaw, Bettina E Hansen, Hannah Choi, Cynthia Wat, Vedran Pavlovic, Anuj Gaggar, Qing Xie, Maria Buti, Robert J de Knegt, Harry L A Janssen. Optimisation of the use of APRI and FIB-4 to rule out cirrhosis in patients with chronic hepatitis B: results from the SONIC-B study. The Lancet Gastroenterology & Hepatology 2019; 4(7): 538 doi: 10.1016/S2468-1253(19)30087-1
|
| 26 |
Chi Zhang, Yiqi Liu, Jiawen Li, Hui Liu, Chen Shao, Dan Liu, Min Yu, Hongli Xi, Hong Zhao, Guiqiang Wang. Dose–response relationship between qAnti‐HBc and liver inflammation in chronic hepatitis B with normal or mildly elevated alanine transaminase based on liver biopsy. Journal of Medical Virology 2022; 94(8): 3911 doi: 10.1002/jmv.27779
|